← Evidence map

TrialAllergy2018

Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels-A pilot study.

J Eckl-Dorna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2018
2019
2020
2021
2022
2023
2024
this papertrialcites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 29083477